XML 50 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
20. Restructuring
12 Months Ended
Dec. 31, 2016
Restructuring and Related Activities [Abstract]  
20. Restructuring

Note 20. Restructuring

On July 7, 2016, the Company announced a restructuring of its sales force and operations. The reorganization plan included (1) a reduction of 54 sales positions, primarily from the Company's Neurology sales team; (2) prioritization and reorganization of sales territories to reduce the inefficient time that sales representatives spent driving long distances between customers; (3) improvement of the Company's compensation plan to incentivize the field sales staff to increase the frequency of calls on the focused targets; and (4) consolidation of the Neurology and Pain sales forces under one sales management structure to eliminate redundancies. In addition, as part of this initiative, the Company reduced its administrative staff by six employees. The Company incurred $2.3 million during the year ended December 31, 2016 in severance and other related cash expenses. The charge during the year ended December 31, 2016 was comprised of $1.3 million in severance related cash expenses, and $1.0 million in other cash related expenses. Associated severance and other related payments are expected to be paid by December 31, 2017.

On March 16, 2015, the Company decided to institute an initiative to restructure operations and shut down the Charleston, South Carolina site. This step was done to consolidate operations within the Company's headquarters located in Morristown, New Jersey. During the year ended December 31, 2015, the Company incurred a charge of $1.1 million related to the restructuring. The charge during the year ended December 31, 2015 was comprised of $485,000 in severance related cash expenses, and $653,000 for the modification and accelerated vesting of options and awards under existing employee agreements. Associated severance payments were paid by May 31, 2016.

A summary of accrued restructuring costs, included as a component of accounts payable and accrued expenses on the consolidated balance sheets, are as follows (in thousands):

      December 31, 2015     Charges     Cash     Non-cash     December 31, 2016
2016 restructuring costs   $ -     $ 2,287    $ (1,669)   $ -     $ 618 
2015 restructuring costs     104      -       (104)     -       -  
     Totals   $ 104    $ 2,287    $ (1,773)   $ -     $ 618 
                               
      December 31, 2014     Charges     Cash     Non-cash     December 31, 2015
2015 restructuring costs   $ -     $ 1,137    $ (380)   $ (653)   $ 104